June 8, 2021

M&A nel settore Life Sciences: uno sguardo multi-disciplinare

16 giugno 2021

Webinar 17:00 – 18:00

Gli aspetti legali delle operazioni di M&A nel Life Sciences, soprattutto nei settori farmaceutico e dei medical devices, richiedono un approccio sistematico e multidisciplinare da calibrare sulle specificità operative, economiche e regolamentari del settore e della singola target.

Nel corso del webinar, identificheremo criticità, trend e best practice, prendendo in considerazione le peculiarità del settore e il loro possibile impatto, sotto il profilo legale, su struttura, valutazione, contenuto ed esecuzione di una operazione di M&A e sui principali meccanismi contrattuali. Facendo riferimento a casi concreti, analizzeremo tematiche M&A connesse agli aspetti regolamentari e di compliance, di appalti pubblici e antitrust fino alle recenti novità in tema di “Golden Power”.

Il seminario si rivolge ad aziende del settore, investitori, banche d’affari e società di consulenza.

Interverranno:

ISCRIVITI

< Back to blog
Welcome to the Portolano Cavallo Life Sciences blog focusing on legal development and key legal issues affecting the life sciences and healthcare industry.
...
Read more
Our highly-ranked team of professionals will provide news, insights and multidisciplinary commentary on the hottest and most recent regulatory, transactional and contentious aspects of the pharmaceutical, bio-tech, med-tech, food supplement and healthcare world with an eye on its digital transformation and technological developments.

This blog will be a place for focusing on digital health, telemedicine and artificial intelligence, as well as more traditional topics: from the protection of intellectual properties to performance of clinical trials, from the market access to advertising and competition issues, from internal and criminal investigations to M&A and venture capital transactions.

Close
October 6, 2023
CBD products: the Administrative Court suspended until October 24 the recent Decree of the Italian Ministry of Health listing cannabidiol for oral use among narcotic drugs, due to the lack o...
October 4, 2023
The Guidelines for regulating contractual relations between universities and research institutes and private sponsors were adopted by the relevant Italian Ministries following the amendment ...
September 21, 2023
CBS products: from September 20th, compositions for oral administration of cannabidiol obtained from Cannabis sativa extracts shall be considered as narcotic drugs in Italy, as they have bee...
July 27, 2023
Payback on medical devices: Italian government announces extension of payment deadline to October 30, 2023
July 21, 2023
On July 21, 2023, the Italian Ministry of Health published new guidelines on health advertising of self-medication drugs (OTC) and non-prescription drugs (SOP), including advertising on new ...
Search by...
Search
Follow us on
Follow us on